LSP-GR1
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
Life Splice Pharma
Mechanism of Action
Glutamate
Mechanism Description
Splice modulating oligomers impacting AMPA receptor (GLUA1) levels
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Government
Nonprofit or Government Support Description
NINDS - SBIR grant
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link